https://www.eapf.org.uk/~/media/document-libraries/eapf2/policies/2023/conflicts-of-interest-policy-agreed-at-june--23-pc--final_v2.pdf?la=en&hash=73A3192F28D6418F742FA515277EE97CA00E8542<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4580", "label" : {"_value" : "Biography information for Baroness Vere of Norbiton"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Vere of Norbiton"}
, "dateOfAnswer" : {"_value" : "2024-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-12T16:40:10.63Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "14"}
, "answeringDeptShortName" : {"_value" : "Treasury"}
, "answeringDeptSortName" : {"_value" : "Treasury"}
, "date" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pension Funds"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what assessment they have made of the practice of the pension funds of regulators investing in companies for which the regulator has oversight responsibility, for example in the recent case of the Environment Agency\u2019s pension fund investing in companies which produce PFAS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1972"}
, {"_about" : "http://data.parliament.uk/resources/1685672", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1685672/answer", "answerText" : {"_value" : "Ministers and officials continue to raise Mr Alaa Abd El-Fattah's case at the highest levels with the Egyptian government and have been consistently clear in our calls for his release, while continuing to press the need for urgent consular access. The Foreign Secretary and I raised his case with President Sisi and Egyptian Foreign Minister Shoukry on 21 December 2023. The Prime Minister also recently raised Mr El-Fattah's case with President Sisi on 1 December 2023.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"}
, "dateOfAnswer" : {"_value" : "2024-02-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-12T16:08:50.947Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "208"}
, "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
, "date" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Alaa Abdel Fattah"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what representations they are making to the government of Egypt regarding the release of the British-Egyptian pro-democracy activist Alaa Abdel Fattah, and whether they have an expectation of the date on which he is likely to be released.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1975"}
, {"_about" : "http://data.parliament.uk/resources/1685674", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1685674/answer", "answerText" : {"_value" : "
As set out in the Government\u2019s Women\u2019s Health Strategy, improving care and support for women experiencing menopause symptoms is a priority for the Government. Helen Tomlinson has been appointed as the Government\u2019s first Menopause Employment Champion and is working with employers to increase understanding of menopause in the workplace and support for women. In October 2023 Helen published a report, No Time to Step Back, which provides guidance to help recruit, support and retain women experiencing the menopause and stop women considering giving up their employment.<\/p>
The Government has also launched a new online only space for guidance on the Help to Grow website, providing businesses, large and small, with the resources they need to help educate their organisation and workers about the menopause.<\/p>
In the 2023 Autumn Statement, the Government published the response to the Occupational Health: Working Better consultation and set out plans to imminently set up an expert group to support the development of a voluntary minimum framework for quality occupational health provision. The voluntary framework will take account of existing initiatives that support those with health conditions and disabilities in the workplace and aims to set out the minimum level of quality occupational health provision that employers can adopt to help employees return to work from sickness absence, and prevent health-related job loss.<\/p>
The Government also announced that it will identify longer-term options to build multidisciplinary workforce capability in work and health, building on existing work with the sector and exploring opportunities for businesses and providers to improve support for their employees. The Occupational Health Workforce Expansion Funding Scheme launched in July 2023 funds doctors and nurses to undertake occupational health training courses and qualifications with 99 Doctors and Nurses funded as part of the first round of applications.<\/p>
In terms of frontline health workers, a key focus of the NHS England National Menopause Care Improvement Programme is the development of a retention programme for the National Health Service workforce, which is looking at how best to support menopausal staff and line managers in NHS settings. In November 2022, NHS England launched Supporting our NHS people through menopause, a guidance document developed for NHS line managers and colleagues. They have launched two e-learning packages, for general guidance and occupational health colleagues, and are developing one for human resources and line managers. A health and wellbeing app, Shiny Mind, is available to the nursing workforce, and launched a menopause specific section in November 2023.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Markham"}
, "dateOfAnswer" : {"_value" : "2024-02-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-02T13:31:53.003Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Menopause: Employment"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to inform and educate employers and occupational health professionals of the specific workplace adaptations that women experiencing menopause symptoms may require, and what assessment they have made of working conditions for frontline health workers experiencing menopause symptoms.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1977"}
, {"_about" : "http://data.parliament.uk/resources/1682796", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682796/answer", "answerText" : {"_value" : "
The UK Government introduced new legislation through the Environment Act to tackle illegal deforestation in UK supply chains. Recent research estimates that around 70% of global tropical deforestation for commercial agriculture between 2013 and 2019 was conducted in violation of national laws.<\/p>
<\/p>
The Government announced further details of our Forest Risk Commodities regulations at COP28 in December. The new law will make it illegal for larger organisations, with a global annual turnover of more than £50m, to use key forest risk commodities produced on land illegally occupied or used. Initial secondary legislation will focus on four commodities identified as key drivers of deforestation: cattle products (excluding dairy), cocoa, palm oil and soy.<\/p>
<\/p>
Organisations in scope will also be required to undertake a due diligence exercise on their supply chains and to report on this exercise annually.\u202fTo ensure transparency, information about businesses' due diligence exercises will be published.\u202f Businesses in scope that do not comply with these requirements may be subject to fines and other civil sanctions. The secondary legislation required to operationalise the Environment Act provisions will be laid as soon as parliamentary time allows.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1547", "label" : {"_value" : "Biography information for Lord Benyon"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Benyon"}
, "dateOfAnswer" : {"_value" : "2024-01-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-23T15:31:28.557Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2024-01-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Forests: Commodities"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they have taken to ensure that regulated persons in relation to forest risk commodities establish and implement due diligence systems in relation to those commodities, as required under the Environment Act 2021.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1678"}
, {"_about" : "http://data.parliament.uk/resources/1682273", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682273/answer", "answerText" : {"_value" : "
The <\/em>NHS Business Services Authority and the National Health Service promote the NHS Low Income Scheme and prescription pre-payment certificates (PPCs) to professionals and patients. It does this through social media, online resources, media releases and healthcare bulletins.<\/p>Our extensive arrangements to help people afford NHS prescription charges, means that almost 89% of prescription items in England are already provided free of charge. For those not exempt from charges, PPCs can be used to cap costs at approximately £2 a week for regular prescriptions.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Markham"}
, "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-22T16:02:27.947Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS Low Income Scheme: Chronic Illnesses"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to promote (1) the NHS Low Income Scheme to chronically ill patients, including Hidradenitis suppurativa patients, and (2) the use of pre-payment prescription certificates to chronically ill patients, including Hidradenitis suppurativa patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1556"}
, {"_about" : "http://data.parliament.uk/resources/1682274", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682274/answer", "answerText" : {"_value" : "
While we are not considering adding this or other conditions to the list of exemptions for free prescriptions, there are extensive arrangements currently in place to ensure that prescriptions are affordable for patients with hidradentis suppurativa.<\/p>
Around 89% of prescriptions are dispensed free of charge and extensive arrangements are already in place to help those with the greatest need. Eligibility depends on the patient\u2019s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Markham"}
, "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-22T16:01:21.867Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hidradenitis Suppurativa: Prescriptions"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what consideration they have given to including Hidradenitis suppurativa (HS) to the list of specified medical conditions qualifying for free prescriptions, given the high out-of-pocket costs for HS patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1557"}
, {"_about" : "http://data.parliament.uk/resources/1682275", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682275/answer", "answerText" : {"_value" : "
As set out in the Government response to the Occupational Health: Working Better<\/em> consultation published last year, the Government will develop a voluntary minimum framework for quality occupational health, aiming to set out the minimum level of provision that employers can adopt to support those with health conditions and disabilities in the workplace. This builds on the development of a digital information and advice service for employers, offering tailored guidance on health and disability, to equip employers to have work and health conversations and signpost to sources of expert support. A copy of the Government response to the consultation is attached.<\/p> <\/p>
The Government also announced that it will identify longer-term options to build multidisciplinary workforce capability in work and health, building on existing work with the sector and exploring opportunities for businesses and providers to improve support for their employees. The Occupational Health Workforce Expansion Funding Scheme launched in July 2023 funds doctors and nurses to undertake occupational health training courses and qualifications with 99 doctors and nurses trained to date.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Markham"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1682275/answer/attachment/1", "fileName" : {"_value" : "occupational-health-working-better-responses.pdf"}
, "title" : "Occupational Health - Working Better"}
, "dateOfAnswer" : {"_value" : "2024-01-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-23T15:35:13.427Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hidradenitis Suppurativa: Employment"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to inform and educate employers and occupational health professionals about the specific workplace adaptations that people with Hidradenitis suppurativa may require.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1558"}
, {"_about" : "http://data.parliament.uk/resources/1682276", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682276/answer", "answerText" : {"_value" : "
We have interpreted your question to refer to healthcare professionals (HCPs) who conduct Work Capability Assessments for Centre for Health and Disability Assessments (CHDA) on behalf of the department, and not Department for Work and Pensions decision makers who make decisions on entitlement to benefit.<\/p>
<\/p>
Assessments are carried out by qualified HCPs, who receive training in assessing the impacts of a variety of disabilities including chronic inflammatory conditions, to ensure they are familiar with the clinical aspects of the conditions and their impact on daily functions.<\/p>
<\/p>
HCPs have access to a wide range of clinical resources, including e-learning modules and case studies, to research any conditions presented. CHDA has a learning module on hidradenitis suppurativa for use by their HCPs that has been externally quality assured by a consultant dermatologist. In addition, HCPs are also expected to keep their knowledge up to date through continuing professional development.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4169", "label" : {"_value" : "Biography information for Viscount Younger of Leckie"}
}
, "answeringMemberPrinted" : {"_value" : "Viscount Younger of Leckie"}
, "dateOfAnswer" : {"_value" : "2024-01-25", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-25T16:10:48.247Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Social Security Benefits: Disability"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to educate assessors of disability benefits, including commissioned assessment services, about chronic inflammatory conditions such as Hidradenitis suppurativa and their impact on individuals' capacity to work.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1559"}
, {"_about" : "http://data.parliament.uk/resources/1682277", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682277/answer", "answerText" : {"_value" : "
In January 2021, and in conjunction with the Social Partnership Forum, NHS England developed and published a national Violence Prevention and Reduction Standard. This supports employers in their efforts to provide a safe and secure working environment for National Health Service staff, with a focus on risk management, training and support for those impacted by incidences of violence or aggression.<\/p>
£8.4 million has been invested into the ambulance service sector to explore the efficacy of body worn cameras in reducing violence and abuse. All ambulance trusts are now trialling cameras and an independent evaluation is underway with a final report expected towards the end of 2024.<\/p>
In 2022, the Government legislated through the Police, Crime, Sentencing and Courts Act to double the sentence for assaults on emergency workers to a maximum of two years.<\/p>
We do not currently have a national mechanism to assess the levels of violence and aggression in the NHS on staffing levels. NHS employing organisations have a duty of care to support the health and safety of their staff and they do collect data on incidents. This is used to inform local strategies for reducing and dealing with violence and aggression.<\/p>
The NHS Staff Survey does ask questions relating to incidences of violence, harassment, and abuse. The 2022 NHS Staff Survey indicated that 14.7% of NHS staff have self-reported that they had experienced at least one incident of physical violence from patients, service users, relatives, or other members of the public in the last 12 months.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Markham"}
, "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-22T17:25:06.77Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Professions: Crimes of Violence"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what steps they are taking to reduce rates of violence experienced by front line healthcare workers; and what assessment they have made of the effect of such violence on staffing levels.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1560"}
, {"_about" : "http://data.parliament.uk/resources/1682278", "AnsweringBody" : [{"_value" : "Department for Business and Trade"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1682278/answer", "answerText" : {"_value" : "
The Personal Protective Equipment Regulation 2016/425 sets out essential safety requirements that PPE must meet. This includes an obligation on the manufacturer to give, if possible, the month and year of obsolescence, if it is known that the design performance may be significantly affected by ageing.<\/p>
<\/p>
The Government has had no discussions with industry about changing this requirement in the Regulation, but welcomes new technological innovation to improve short PPE use-by dates.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4931", "label" : {"_value" : "Biography information for Lord Offord of Garvel"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Offord of Garvel"}
, "dateOfAnswer" : {"_value" : "2024-01-31", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-01-31T15:03:19.573Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "214"}
, "answeringDeptShortName" : {"_value" : "Business and Trade"}
, "answeringDeptSortName" : {"_value" : "Business and Trade"}
, "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Protective Clothing: Manufacturing Industries"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask His Majesty's Government what discussions they have had with the personal protective equipment (PPE) industry about regulatory and technological solutions to improve short PPE use-by dates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
], "uin" : "HL1561"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&_page=1&max-questionFirstAnswered.=2024-02-12T16%3A40%3A10.63Z", "page" : 0, "startIndex" : 1, "totalResults" : 776, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}